Market Overview:
The global dermatological disorders medications market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of skin diseases, rising awareness about available treatments, and growing demand for prescription and over-the-counter drugs. Based on type, the global dermatological disorders medications market is segmented into prescription drugs and over-the-counter drugs. Prescription drugs are further subsegmented into topical corticosteroids, calcineurin inhibitors, antifungals, antibiotics/antibacterials agents; retinoids; psoralens plus ultraviolet A (PUVA) therapy; immunosuppressants; tumor necrosis factor inhibitors (TNFi); biologics for plaque psoriasis (mAbs); and others. Topical corticosteroids are expected to account for the largest share of the prescription drug segment in 2018 owing to their high efficacy in treating various skin conditions such as eczema and psoriasis. Over-the-counter drugs are further subsegmented into moisturizers/emollients; sunscreens/sunblocks; antihistamines; acne treatments products including benzoyl peroxide & salicylic acid preparations ; wart removers ; dandruff shampoos ; calamine lotion & other soothing agents .
Product Definition:
A dermatological disorder is a condition that affects the skin. There are many different types of dermatological disorders, and they can range in severity from mild to life-threatening. Some common dermatological disorders include acne, eczema, psoriasis, and skin cancer.
Dermatological disorders can be treated with a variety of medications, including antibiotics, anti-inflammatory drugs, and topical treatments. These medications can help to improve the appearance and health of the skin affected by these conditions.
Prescription Drugs:
Prescription drugs are the ones that are given to patients by doctors or other healthcare professionals after evaluating the possible benefits and risks for a particular patient. The drug is then prescribed by name, based on its indications. For instance, antibiotics can be prescribed for bacterial infections and anti-inflammatory drugs can be used in case of inflammatory conditions like rheumatoid arthritis.
Over-The-Counter Drugs:
Over-the-counter (OTC) drugs are medications that are available for the public without a prescription. OTC drugs include products such as cold and cough medicines, skin care products, vitamins, minerals, and herbal supplements. Most OTC medications can be purchased from retail or online stores without a prescription; however some require a prescription from healthcare professionals.
The global OTC drugs.
Application Insights:
The general dermatological disorders segment dominated the market with a share of 29.1% in 2017. The increasing prevalence of skin diseases, especially chronic wounds and acne, is contributing to the growth of this segment. For instance, as per the National Center for Biotechnology Information (NCBI) in 2017, acne affects around 40 million people across the world and approximately 1 billion dollars are spent on treatment related to acne every year. Thus, growing awareness about various treatments for these skin conditions is expected to fuel product demand over the forecast period.
The hair & scalp disorders segment is anticipated to witness lucrative growth during the study period owing to an increase in hair fall problems among both men.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the presence of a large number of dermatology clinics and hospitals, high disease prevalence, higher healthcare expenditure levels, and well-established healthcare infrastructure. Moreover, an increase in R&D activities by major companies for development of new drugs is expected to fuel growth during the forecast period.
Asia Pacific is estimated to grow at a lucrative rate over the forecast period owing to increasing disposable income levels and growing patient awareness about early diagnosis & treatment options for various skin disorders. Furthermore, government initiatives such as “One Belt One Road†(OBOR) project undertaken by China are expected to open up new markets for Chinese manufacturers offering cost-effective products with high quality standards.
Growth Factors:
- Increasing incidence of dermatological disorders
- Growing awareness about the available treatment options for dermatological disorders
- Rising demand for better and more effective treatments for dermatological disorders
- Technologically advanced and novel medications being developed for the treatment of dermatological disorders
- Availability of government funding and support to help research and develop new medications for the treatment of dermatological disorders
Scope Of The Report
Report Attributes
Report Details
Report Title
Dermatological Disorders Medications Market Research Report
By Type
Prescription Drugs, Over-The-Counter Drugs
By Application
Hospital Pharmacies, Online Pharmacies, Retail Pharmacies
By Companies
Mylan Pharmaceuticals, Pfizer, Roche, Almirall, Bausch Health, Barrier Therapeutics, PharmaDerm, Bristol-Myers Squibb, Galderma, GlaxoSmithKline, Novartis, Sinclair Pharma
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
137
Number of Tables & Figures
96
Customization Available
Yes, the report can be customized as per your need.
Global Dermatological Disorders Medications Market Report Segments:
The global Dermatological Disorders Medications market is segmented on the basis of:
Types
Prescription Drugs, Over-The-Counter Drugs
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital Pharmacies, Online Pharmacies, Retail Pharmacies
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Mylan Pharmaceuticals
- Pfizer
- Roche
- Almirall
- Bausch Health
- Barrier Therapeutics
- PharmaDerm
- Bristol-Myers Squibb
- Galderma
- GlaxoSmithKline
- Novartis
- Sinclair Pharma
Highlights of The Dermatological Disorders Medications Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Prescription Drugs
- Over-The-Counter Drugs
- By Application:
- Hospital Pharmacies
- Online Pharmacies
- Retail Pharmacies
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Dermatological Disorders Medications Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Dermatological disorders medications are used to treat various skin conditions. These medications can be prescribed by a doctor, and may include topical creams, ointments, lotions, pills or injections.
Some of the key players operating in the dermatological disorders medications market are Mylan Pharmaceuticals, Pfizer, Roche, Almirall, Bausch Health, Barrier Therapeutics, PharmaDerm, Bristol-Myers Squibb, Galderma, GlaxoSmithKline, Novartis, Sinclair Pharma.
The dermatological disorders medications market is expected to grow at a compound annual growth rate of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Dermatological Disorders Medications Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Dermatological Disorders Medications Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Dermatological Disorders Medications Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Dermatological Disorders Medications Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Dermatological Disorders Medications Market Size & Forecast, 2020-2028
4.5.1 Dermatological Disorders Medications Market Size and Y-o-Y Growth
4.5.2 Dermatological Disorders Medications Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Prescription Drugs
5.2.2 Over-The-Counter Drugs
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospital Pharmacies
6.2.2 Online Pharmacies
6.2.3 Retail Pharmacies
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Dermatological Disorders Medications Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Dermatological Disorders Medications Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Prescription Drugs
9.6.2 Over-The-Counter Drugs
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospital Pharmacies
9.10.2 Online Pharmacies
9.10.3 Retail Pharmacies
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Prescription Drugs
10.6.2 Over-The-Counter Drugs
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospital Pharmacies
10.10.2 Online Pharmacies
10.10.3 Retail Pharmacies
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Prescription Drugs
11.6.2 Over-The-Counter Drugs
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospital Pharmacies
11.10.2 Online Pharmacies
11.10.3 Retail Pharmacies
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Prescription Drugs
12.6.2 Over-The-Counter Drugs
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospital Pharmacies
12.10.2 Online Pharmacies
12.10.3 Retail Pharmacies
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Prescription Drugs
13.6.2 Over-The-Counter Drugs
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospital Pharmacies
13.10.2 Online Pharmacies
13.10.3 Retail Pharmacies
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Dermatological Disorders Medications Market: Competitive Dashboard
14.2 Global Dermatological Disorders Medications Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Mylan Pharmaceuticals
14.3.2 Pfizer
14.3.3 Roche
14.3.4 Almirall
14.3.5 Bausch Health
14.3.6 Barrier Therapeutics
14.3.7 PharmaDerm
14.3.8 Bristol-Myers Squibb
14.3.9 Galderma
14.3.10 GlaxoSmithKline
14.3.11 Novartis
14.3.12 Sinclair Pharma
